Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immunic Inc
(NQ:
IMUX
)
1.630
+0.060 (+3.82%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immunic Inc
< Previous
1
2
3
4
5
6
Next >
Peek Behind the Curtain: 7 Penny Stocks With Heavy Insider Buying
May 23, 2024
While speculative ideas are treacherous, you can possibly reduce your blood pressure with these penny stocks with insider buying.
Via
InvestorPlace
Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day
May 20, 2024
Immunic Inc (NASDAQ:IMUX) chief medical officer Dr Andreas Muehler discusses the importance of clinical trials in the biotech industry to mark Clinical Trials Day on May 20.
Via
TheNewswire.com
Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day
May 20, 2024
Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day
Via
News Direct
Immunic chief medical officer discusses promising treatments to mark World IBD Day
May 17, 2024
Immunic chief medical officer discusses promising treatments to mark World IBD Day
Via
News Direct
Immunic chief medical officer discusses promising treatments to mark World IBD Day
May 17, 2024
Immunic Inc (NASDAQ:IMUX) chief medical officer Dr Andreas Muehler discusses Inflammatory Bowel Disease (IBD) with Proactive's Stephen Gunnion to mark World IBD Day on May 19.
Via
TheNewswire.com
IMUX Stock Earnings: Immunic Misses EPS for Q1 2024
May 08, 2024
IMUX stock results show that Immunic missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Immunic's Earnings Outlook
February 21, 2024
Via
Benzinga
Immunic: Q3 Earnings Insights
November 14, 2023
Via
Benzinga
A Preview Of Immunic's Earnings
November 13, 2023
Via
Benzinga
Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day
May 16, 2024
Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day
Via
News Direct
Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day
May 16, 2024
Immunic Inc (NASDAQ:IMUX) chief scientific officer Hella Kohlhof joined Proactive's Stephen Gunnion on International Celiac Day, in the middle of Celiac Disease Awareness Month, to discuss the disease...
Via
TheNewswire.com
Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones
May 09, 2024
Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones
Via
News Direct
Topics
Intellectual Property
Exposures
Intellectual Property
Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones
May 09, 2024
Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt takes Proactive's Stephen Gunnion through the company's first-quarter achievements and upcoming milestones for its clinical pipeline of orally administered,...
Via
TheNewswire.com
Topics
Intellectual Property
Exposures
Intellectual Property
Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal
May 01, 2024
Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal
Via
News Direct
Immunic "super excited" about latest PMS trial data
October 11, 2023
--News Direct--
Via
News Direct
Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal
May 01, 2024
Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt joined Proactive's Stephen Gunnion with news of the publication of extended data from the Phase 2 EMPhASIS trial of vidofludimus calcium in...
Via
TheNewswire.com
Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month
March 21, 2024
--News Direct--
Via
News Direct
Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month
March 21, 2024
Immunic Inc (NASDAQ:IMUX) Chief Medical Officer Dr Andreas Muehler discusses the complexities of multiple sclerosis (MS) during an interview with Proactive's Stephen Gunnion to mark MS Awareness Month,...
Via
TheNewswire.com
Immunic And 2 Other Stocks Under $2 Insiders Are Buying
February 29, 2024
The Dow Jones index closed lower by over 20 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What's Going On With Immunic Stock?
January 05, 2024
Immunic, Inc. (NASDAQ: IMUX) shares are roughly flat following strength early Friday after the company announced a three-tranche private placement of up to $240 million.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 05, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
January 05, 2024
Pre-market stock movers are worth checking on Friday as we lay out all of the biggest stories worth keeping tabs on this morning!
Via
InvestorPlace
Immunic CSO hails "great" progress with MS program
October 24, 2023
--News Direct--
Via
News Direct
Immunic CSO hails "great" progress with MS program
October 24, 2023
Immunic Inc (NASDAQ:IMUX) Chief Scientific Officer Hella Kohlhof speaks to Thomas Warner at the Proactive London after returning from MSMilan2023, the 9th Joint ECTRIMS-ACTRIMS meeting. She shares some...
Via
TheNewswire.com
Immunic "super excited" about latest PMS trial data
October 11, 2023
Immunic Inc (NASDAQ:IMUX) President and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive after the biotechnology company announced encouraging interim data from its phase II CALLIPER trial...
Via
TheNewswire.com
Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 10, 2023
Gainers SuperCom Ltd. (NASDAQ: SPCB) shares jumped 89% to $0.6805, after falling 13% on Monday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 10, 2023
Via
Benzinga
Multiple Sclerosis Impacts 1M People In US - Immunic Reveals 'Positive' Data From Nerve Disorder Candidate
October 10, 2023
Immunic Inc (NASDAQ: IMUX) announced interim data from its phase 2 CALLIPER trial of nuclear receptor-related 1 (Nurr1) activator, vidofludimus calcium (IMU-838), in patients with
Via
Benzinga
Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
October 10, 2023
Gainers SuperCom Ltd. (NASDAQ: SPCB) shares rose 78.4% to $0.6425 in pre-market trading, after falling 13% on Monday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 10, 2023
It's time to dive into the biggest pre-market stock movers with all the most recent news moving shares on Tuesday morning!
Via
InvestorPlace
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.